Abstract
Ziprasidone is a second-generation antipsychotic with a lower propensity to cause extrapyramidal adverse effects that are seen at higher doses. We report a patient who developed acute dystonia, parkinsonism, and severe akathisia with ziprasidone 80 mg/d. These adverse effects subsided after dose reduction and specific treatment for akathisia and parkinsonism.
| Original language | English |
|---|---|
| Pages (from-to) | e38-e40 |
| Journal | American Journal of Therapeutics |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 01-01-2014 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Acute dystonia, akathisia, and parkinsonism induced by ziprasidone'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver